X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (77) 77
index medicus (62) 62
oncology (55) 55
female (48) 48
adult (46) 46
male (46) 46
middle aged (38) 38
aged (29) 29
sarcoma (29) 29
sarcoma - drug therapy (24) 24
cancer (23) 23
treatment outcome (23) 23
adolescent (22) 22
disease-free survival (21) 21
young adult (21) 21
article (19) 19
chemotherapy (18) 18
analysis (17) 17
antineoplastic agents - therapeutic use (17) 17
imatinib mesylate (16) 16
prognosis (16) 16
child (13) 13
bone neoplasms - drug therapy (12) 12
physics, particles & fields (12) 12
sarcoma - pathology (12) 12
aged, 80 and over (11) 11
expression (11) 11
research (11) 11
soft-tissue sarcomas (11) 11
hadron-hadron scattering (10) 10
kaplan-meier estimate (10) 10
surgery (10) 10
therapy (10) 10
tumors (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
clinical trials (9) 9
drug administration schedule (9) 9
experiment (9) 9
imatinib (9) 9
physics (9) 9
sarcoma - mortality (9) 9
soft tissue neoplasms - drug therapy (9) 9
usage (9) 9
care and treatment (8) 8
doxorubicin (8) 8
infant (8) 8
neoplasm staging (8) 8
piperazines - therapeutic use (8) 8
pregnancy (8) 8
pregnant women (8) 8
pyrimidines - therapeutic use (8) 8
survival (8) 8
benzamides (7) 7
chemotherapy, adjuvant (7) 7
children (7) 7
fluorodeoxyglucose f18 (7) 7
high energy physics (7) 7
neurosciences (7) 7
phase-ii trial (7) 7
114 physical sciences (6) 6
abridged index medicus (6) 6
antineoplastic agents - adverse effects (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
bone neoplasms - pathology (6) 6
child, preschool (6) 6
chordoma (6) 6
cocaine (6) 6
diagnosis (6) 6
follow-up studies (6) 6
high energy physics - experiment (6) 6
ifosfamide (6) 6
immunohistochemistry (6) 6
neoadjuvant therapy (6) 6
osteosarcoma (6) 6
pathology (6) 6
positron-emission-tomography (6) 6
risk factors (6) 6
soft tissue neoplasms - mortality (6) 6
soft tissue neoplasms - pathology (6) 6
soft tissue sarcoma (6) 6
sunitinib (6) 6
survival analysis (6) 6
trial (6) 6
activation (5) 5
antibodies, monoclonal - therapeutic use (5) 5
antineoplastic agents - administration & dosage (5) 5
behavior problems (5) 5
bone (5) 5
bone neoplasms - mortality (5) 5
chondrosarcoma (5) 5
disease progression (5) 5
doxorubicin - administration & dosage (5) 5
fusion (5) 5
gastrointestinal stromal tumors (5) 5
gastrointestinal stromal tumors - pathology (5) 5
gemcitabine (5) 5
health aspects (5) 5
hematology, oncology and palliative medicine (5) 5
management (5) 5
medicine & public health (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Journal (United States), ISSN 1528-9117, 2017, Volume 23, Issue 2, pp. 92 - 94
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 4, pp. 371 - 382
Summary Background Preclinical studies have shown synergistic antitumour activity by inhibition of insulin-like growth factor-1 receptor (IGF-1R) and mTOR. The... 
Hematology, Oncology and Palliative Medicine | INSULIN | RAPAMYCIN | ACTIVATION | ONCOLOGY | ANTIBODY | INHIBITOR | FACTOR-I RECEPTOR | EXPRESSION | FAMILY | Bone Neoplasms - mortality | Receptor, IGF Type 1 - metabolism | Receptor, IGF Type 1 - antagonists & inhibitors | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | TOR Serine-Threonine Kinases - metabolism | Drug-Related Side Effects and Adverse Reactions - chemically induced | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Protein Kinase Inhibitors - adverse effects | Bone Neoplasms - pathology | Drug-Related Side Effects and Adverse Reactions - pathology | TOR Serine-Threonine Kinases - antagonists & inhibitors | Neoplasm Grading | Sarcoma - mortality | Aged, 80 and over | Adult | Female | Bone Neoplasms - drug therapy | Sirolimus - adverse effects | Sirolimus - analogs & derivatives | Sarcoma - drug therapy | Sarcoma - pathology | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Sirolimus - administration & dosage | Antibodies, Monoclonal - administration & dosage | Receptor, IGF Type 1 - immunology | Aged | Antimitotic agents | Care and treatment | Chemotherapy | Sarcoma | Product development | Antineoplastic agents | Cancer
Journal Article
Sarcoma, ISSN 1357-714X, 2019, Volume 2019, pp. 1960593 - 6
Primary cardiac sarcoma (PCS) has a poor prognosis compared to other sarcomas due to late presentation, challenging resection, incidence of metastases, and... 
Journal Article
The Lancet Oncology, ISSN 1470-2045, 11/2017, Volume 18, Issue 11, pp. 1493 - 1501
Journal Article
Nature Genetics, ISSN 1061-4036, 02/2013, Volume 45, Issue 2, pp. 180 - 185
Journal Article
Journal Article
Journal of Bone and Joint Surgery, ISSN 0021-9355, 2014, Volume 96, Issue 2, pp. 152 - 158
Background Our previous research investigated the ability of [F-18]fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging results to predict... 
Orthopedics
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2012, Volume 30, Issue 1, pp. 78 - 84
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 05/2016, Volume 57, Issue 5, pp. 735 - 735
The aim of this study was to assess the prognostic and predictive value of early quantitative super( 18)F-FDG PET to monitor therapy with an antibody to the... 
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 05/2016, Volume 57, Issue 5, p. 735
  The aim of this study was to assess the prognostic and predictive value of early quantitative ^sup 18^F-FDG PET to monitor therapy with an antibody to the... 
Survival analysis | Nuclear medicine | Tomography | Monoclonal antibodies | Insulin-like growth factors | Radiation therapy | Tumors
Journal Article
Expert Opinion on Orphan Drugs, ISSN 2167-8707, 12/2017, Volume 5, Issue 12, pp. 983 - 989
Introduction: Epithelioid sarcoma (ES) is a rare malignancy of mesenchymal origin that accounts for <1% of soft tissue sarcomas. Research in ES has been... 
Epithelioid sarcoma | SMARCB1 | drug therapy | INI1 | ACTIVATION | NODE BIOPSY | COMPLEXES | POLYCOMB | GROWTH-FACTOR RECEPTOR | INHIBITION | IMMUNOHISTOCHEMICAL ANALYSIS | GENE AMPLIFICATION | PHARMACOLOGY & PHARMACY | PROXIMAL-TYPE | EXPRESSION
Journal Article
Journal Article
Journal of Surgical Oncology, ISSN 0022-4790, 12/2011, Volume 104, Issue 8, pp. 888 - 895
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2007, Volume 25, Issue 19, pp. 2755 - 2763
Purpose Gemcitabine as a single agent and the combination of gemcitabine and docetaxel have activity in patients with metastatic soft tissue sarcoma. To... 
TRIAL | RESISTANT | SOLID TUMORS | ONCOLOGY | DOXORUBICIN | ACUTE STROKE | ADAPTIVE DOSE-RESPONSE | EUROPEAN-ORGANIZATION | IFOSFAMIDE | CANCER | CHEMOTHERAPY
Journal Article
Cancer, ISSN 0008-543X, 01/2017, Volume 123, Issue 1, pp. 90 - 97
Journal Article